American International Group’s Kymera Therapeutics KYMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-20,095	Closed	-$808K	–	1450
2024 Q1	$808K	Buy	20,095 +1,209	+6%	+$43.3K	﹤0.01%	1411
2023 Q4	$481K	Sell	18,886 -76	-0.4%	-$1.36K	﹤0.01%	1682
2023 Q3	$264K	Buy	18,962 +674	+4%	+$13.6K	﹤0.01%	1970
2023 Q2	$420K	Buy	18,288 +39	+0.2%	+$1.12K	﹤0.01%	1759
2023 Q1	$541K	Buy	18,249 +363	+2%	+$11.7K	﹤0.01%	1556
2022 Q4	$446K	Sell	17,886 -65	-0.4%	-$1.73K	﹤0.01%	1655
2022 Q3	$391K	Buy	17,951 +253	+1%	+$6.67K	﹤0.01%	1728
2022 Q2	$348K	Buy	17,698 +638	+4%	+$14.9K	﹤0.01%	1828
2022 Q1	$722K	Sell	17,060 -1,201	-7%	-$50.7K	﹤0.01%	1516
2021 Q4	$1.16M	Sell	18,261 -546	-3%	-$31.8K	0.01%	1334
2021 Q3	$1.1M	Buy	18,807 +2,609	+16%	+$151K	0.01%	1389
2021 Q2	$786	Buy	16,198 +10,321	+176%	+$448K	﹤0.01%	1647
2021 Q1	$228	Buy	5,877 +16	+0.3%	+$963	﹤0.01%	2300
2020 Q4	$363	Buy	+5,861	New	+$286K	﹤0.01%	1931